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Summary
Proneural proteins play a central role in vertebrate
neurogenesis, but little is known of the genes that
they regulate and of the factors that interact with pro-
neural proteins to activate a neurogenic program.
Here, we demonstrate that the proneural protein
Mash1 and the POU proteins Brn1 and Brn2 interact
on the promoter of the Notch ligand Delta1 and syner-
gistically activate Delta1 transcription, a key step in
neurogenesis. Overexpression experiments in vivo
indicate that Brn2, like Mash1, regulates additional
aspects of neurogenesis, including the division of pro-
genitors and the differentiation and migration of neu-
rons.We identify by in silico screening a number of ad-
ditional candidate target genes, which are recognized
by Mash1 and Brn proteins through a DNA-binding
motif similar to that found in the Delta1 gene and pres-
ent a broad range of activities. We thus propose that
Mash1 synergizes with Brn factors to regulate multiple
steps of neurogenesis.
*Correspondence: fguille@nimr.mrc.ac.ukIntroduction
The generation of new neurons by progenitor cells in
the developing central nervous system (CNS) involves
a number of precisely orchestrated steps. As they un-
dergo their last cell division, progenitors become com-
mitted to the neuronal fate and select a unique neuronal
subtype identity (Edlund and Jessell, 1999). Soon after
becoming postmitotic, neurons migrate out of the pro-
genitor zone along specific migration routes (Marin
and Rubenstein, 2003) and begin to differentiate.
Proneural proteins play a central role in neurogenesis
by coordinately regulating many aspects of the neuro-
genic process (Bertrand et al., 2002). Mash1 and Neuro-
genins, the main proneural proteins in mammals, pro-
mote the neuronal commitment of multipotent neural
progenitors, contribute to the specification of neuronal
subtype identities, drive neuronal progenitors out of
the cell cycle, inhibit the differentiation of neighboring
progenitors by activating a Notch-mediated process of
lateral inhibition, and promote neuronal migration (Ber-
trand et al., 2002; Ge et al., 2006; Hand et al., 2005;
Nakada et al., 2004). These multiple functions must in-
volve the activation of numerous target genes. Little is
known of the mechanisms that govern the selection by
a proneural protein of its specific targets and of the na-
ture of these targets. Tissue-specific basic-helix-loop-
helix (bHLH) transcription factors, such as proneural
proteins, are thought to exert their activity by forming
heterodimers with ubiquitously expressed bHLH pro-
teins, including the E2A gene products E12 and E47,
and by binding to a six base pair motif (CANNTG) called
E-box in promoters of target genes (Massari and Murre,
2000). There is evidence to suggest that different bHLH
proteins preferentially bind to specific subsets of E-
boxes (Bertrand et al., 2002; Powell et al., 2004). How-
ever, specific binding to subsets of E-boxes cannot
alone account for the recognition by proneural proteins
of their target promoters since a transcription factor that
interacts with a unique six base pair sequence would
recognize 740,000 sites in a genome of a size of 3 3
109 base pairs, much more than the total number of
genes in a mammalian genome (Kondoh et al., 2004).
Thus, other mechanisms must contribute to the speci-
ficity of target gene recognition by proneural proteins.
Interaction between DNA-binding proteins has been
shown to play an essential role in the selection of target
promoters by a number of transcription factors, such as
Sox proteins (Kondoh et al., 2004). Examples of interac-
tions between bHLH proteins and other transcription
factors, including homeodomain (HD) proteins and LIM
proteins (Bertrand et al., 2002; Westerman et al., 2003),
have also been documented. In Drosophila, the proneu-
ral bHLH protein Achaete interacts with the zinc finger
protein Pannier via the adaptor LIM protein NLI/Chip to
activate an enhancer in the achaete/scute complex
(Ramain et al., 2000). In vertebrates, structure-function
studies suggest that the properties of different proneu-
ral proteins diverge because they interact with different
cofactors; however, the identity of such cofactors has
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832remained elusive (e.g., Nakada et al., 2004; Quan et al.,
2004). The cooperation of the LIM-HD proteins Islet1
and Lhx3 with the neural bHLH protein NeuroM results
in synergistic activation of the motor neuron determina-
tion geneHb9 (Lee and Pfaff, 2003), providing to date the
best example of factors functionally interacting with
a vertebrate neural bHLH protein. The molecular mech-
anism underlying the cooperation between NeuroM and
the Isl1:Lhx3:NLI/Chip complex has not yet been eluci-
dated (Lee and Pfaff, 2003).
We have begun to characterize the mechanisms un-
derlying the functions of the proneural protein Mash1
in neurogenesis, and we asked, in particular, whether
Mash1 activity involves interactions with DNA-binding
cofactors. In the approach reported here, we focused
initially on the regulation by Mash1 of the gene encoding
the Notch ligand, Delta1. Activation of Delta genes by
proneural factors is an evolutionarily conserved step in
neurogenesis that results in activation of Notch signal-
ing and the maintenance of an undifferentiated state in
a subset of neural progenitors (Artavanis-Tsakonas
et al., 1999). We show that activation of mouseDelta1 in-
volves cooperative binding of Mash1 and a Brn factor,
a member of the class III POU family of HD proteins, to
an evolutionarily conserved motif in the Delta1 gene.
We identify additional common targets of Mash1 and
Brn proteins associated with the same motif and dem-
onstrate that Brn factors regulate other aspects of neu-
rogenesis than Notch signaling, including the cell cycle
exit of progenitors and the initiation of neuronal differ-
entiation and radial migration of neurons. Together,
these data reveal an unexpected role for Brn factors
in neural development and suggest that Mash1 and
Brn proteins synergistically regulate a number of target
genes that control multiple aspects of the neurogenic
program.
Results
Mash1 and Neurogenins Activate Delta1
Transcription through Distinct Enhancers
Delta1 is a common target of the proneural genesMash1
and Neurogenin1/2 in mouse embryos (Casarosa et al.,
1999; Fode et al., 2000). To determine whether Mash1
and Neurogenin1/2 directly transcribe Delta1, we first
analyzed the regulatory sequences of this gene. Two
evolutionarily conserved enhancers active in different
CNS regions have been previously identified in the
Delta1 gene (Beckers et al., 2000) (Figure 1A). To deter-
mine whether these enhancers mediate the regulation of
Delta1 by proneural genes, we generated transgenic
mouse lines. A transgene containing the full-length 4.3
kb mouse Delta1 promoter driving lacZ was expressed
broadly in the embryonic brain and spinal cord at
E11.5, in a pattern similar to that of endogenous Delta1
(Beckers et al., 2000). A transgene containing the proxi-
mal Delta1 neural enhancer (hereafter called DeltaM)
and a minimal promoter driving lacZ was, in contrast,
only expressed in parts of the Delta1 expression do-
main, including the dorsal spinal cord and ventral telen-
cephalon, which also express Mash1 (Figure 1B). A
transgene containing the distalDelta1 enhancer (hereaf-
ter called DeltaN) driving lacZ was expressed in a com-
plementary manner in the neural tube, including theventral spinal cord and dorsal telencephalon, which
also express Ngn1 and Ngn2 (Figure 1C). To test
whether these enhancers are regulated by proneural
genes, the transgenic lines were bred with proneural
null mutant mice. On a Mash1 null mutant background
(Guillemot et al., 1993), the DeltaM-lacZ transgene was
not expressed in the CNS at E11.5 (Figure 1B), demon-
strating that the DeltaM enhancer requires Mash1 func-
tion for its activation. On a Ngn1;Ngn2 double mutant
background (Fode et al., 2000), the DeltaN-lacZ trans-
gene showed reduced expression in the spinal cord
and was not expressed in the brain, except near the
hindbrain border, showing that the DeltaN enhancer is
activated by Neurogenins (Figure 1C and data not
shown).
We next asked whether proneural proteins directly in-
teract with the Delta1 enhancers in the embryonic CNS
by performing chromatin immune precipitation (ChIP)
experiments (Figure 1D). An antibody to Mash1 copreci-
pitated the DeltaM sequence in chromatin prepared
from E12.5 wild-type telencephalon, but not from
Mash1 mutant telencephalon, and the antibody did not
precipitate the DeltaN sequence or the Delta1 coding
sequence. Conversely, an antibody to Ngn2 coprecipi-
tated the DeltaN sequence from wild-type, but not
from Ngn2 null mutant telencephalon, and it did not
precipitate the DeltaM or Delta1 coding sequences.
Therefore, Mash1 and Ngn2 specifically bind in vivo to
the DeltaM and DeltaN enhancers, respectively.
Activation of the DeltaM Enhancer Involves
Two E-Boxes and an Octamer Motif
To further examine the interaction of Mash1 with the
DeltaM enhancer, we performed transcription assays
in P19 cells (Farah et al., 2000). We first verified that
Mash1 induces Delta1 transcription in these cells. After
transfection of P19 cells with a Mash1 expression vec-
tor, the Mash1 transcript level increased in less than
4 hr, while the Delta1 transcript level increased less than
3 hr later (Figure 2A), suggesting that Delta1 is directly
transcribed by Mash1 in this system. By performing
ChIP experiments with the Mash1 antibody on Mash1-
transfected and mock-transfected P19 cells, we showed
that Mash1 specifically binds to the DeltaM sequence
(Figure 2B), indicating that Mash1 uses the same en-
hancer element to activate Delta1 in P19 cells and in
the embryo. To examine the regulation of DeltaM by
Mash1, we inserted the DeltaM sequence in a luciferase
reporter vector and tested its transcriptional activity in
P19 cells. The DeltaM reporter was strongly activated
when cotransfected with a Mash1 expression construct
(Figure 2C). This activation was specific, as it was not
observed with a Ngn2 expression construct and Mash1
did not activate a DeltaN reporter (Figure 2C and data
not shown). This assay could thus be used to character-
ize the cis-regulatory sequences and DNA-binding fac-
tors involved in the activation of Delta1 by Mash1.
We identified in the DeltaM sequence two E-boxes
(hereafter called E1-box and E2-box) that are completely
conserved in the human, mouse, chick, and zebrafish
Delta1/DeltaD gene (Figure 2D and data not shown).
To test whether these motifs mediate the direct binding
of Mash1 to DeltaM, we mutated the two E-boxes either
separately or together and examined the activity of the
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833Figure 1. Mash1 and Neurogenins Interact with Distinct Enhancers in the Delta1 Gene
(A) Schematic of mouse Delta1 and zebrafish DeltaD genes showing the position of two evolutionarily conserved neural enhancers (red box,
DeltaN; green box, DeltaM).
(B) X-gal-stained E11.5 wild-type (WT) andMash1 null mutant (Mash1 KO) embryos carrying the transgeneDeltaM-Delta1minimal promoter-lacZ
(DeltaM-lacZ). Right panels show enlargements of the ventral telencephalic region (top) of the two transgenic embryos shown in the left and
cross-sections through their spinal cords (bottom).
(C) X-gal-stained E11.5 wild-type embryo carrying the transgene DeltaN-Delta1 minimal promoter-lacZ (DeltaN-lacZ). Right panels show heads
of E11.5DeltaN-lacZ transgenic embryos in wild-type (WT),Ngn1 null mutant (Ngn1 KO),Ngn2 null mutant (Ngn2 KO), andNgn1/Ngn2 double null
mutant (Ngn1 KO Ngn2 KO) backgrounds. Note the ectopic X-gal staining, e.g., in limbs.
(D) Chromatin immunoprecipitation (ChIP) analysis of the binding of Ngn2 (left histogram) and Mash1 (right histogram) to Delta1 enhancers in
chromatin prepared from the telencephalon of E12.5 wild-type (black bars) and Mash1 null or Ngn2 null mutant embryos (white bars). Data
are presented as the mean 6 SD of triplicate quantifications from at least two immunoprecipitations.resulting DeltaM mutants. Mutation of each E-box sepa-
rately or the two E-boxes together abolished activation
of DeltaM by Mash1 (Figure 2E and data not shown)
and severely reduced the capacity of Mash1 to activate
the full-length Delta1 promoter in P19 cells (Figure 2E). A
shorter version of DeltaM that mostly contains the 2 E-
boxes and the 17 nucleotides in between (DeltaM short;
Figure 2D) was activated by Mash1 as efficiently as
DeltaM (Figure 2C).
To determine whether activation of DeltaM by Mash1
involves motifs other than the two E-boxes, we mutated
the DeltaM short element further. Interestingly, a perfect
evolutionarily conserved consensus binding site for the
POU family of homeodomain proteins, or octamer (Nish-
imoto et al., 2003), is present in this element, one nucle-
otide 50 from the E2-box (Figure 2D). Point mutations in
each half-site of the octamer motif, octT64G and octC68G
(Figure 2D), known to disrupt the interaction of the
octamer with the homeodomain (POUH) and the POU-
specific domain (POUS) of POU factors, respectively
(Nishimoto et al., 2003), abolished activation of DeltaM
short by Mash1, and the same mutations introduced in
the complete DeltaM element or the full-length Delta1
promoter also severely reduced their activation by
Mash1 (Figure 2F and data not shown). This raised the
possibility that activation of Delta1 by Mash1 requires
binding of both Mash1 and a POU protein to adjacent
motifs in the DeltaM enhancer.Activation of the DeltaM Enhancer Requires
Interaction between Mash1 and a POU Protein
The proximity of the two sites suggested that binding of
Mash1 to the E2-box might be influenced by binding of
a putative POU protein to the adjacent octamer. To ad-
dress this possibility, we generated a luciferase reporter
vector containing the multimerized E2 sequence and
a minimal promoter (E26 construct), so that the interac-
tion of Mash1 with E2 could be analyzed in P19 cells in-
dependently of the rest of the DeltaM element. As a con-
trol, we also generated a reporter construct containing
multiple copies of the E1-box (E16). Mash1 activated
the E16 construct very efficiently, while Ngn2 had no ac-
tivity, suggesting that Mash1 specifically binds to the
E1-box (Figure 3A). Mash1 also activated the E26 con-
struct, whereas Ngn2 did not. However, activation of
E26 was weaker (w40-fold) than that of E16 (w350-
fold), suggesting that Mash1 interacts less efficiently
with E2 than with E1 (Figure 3A). We asked whether
the octamer sequence adjacent to E2 had an effect on
the Mash1::E2 interaction by generating a reporter con-
struct containing three copies of a sequence containing
both the octamer and the E2-box in the same configura-
tion as in DeltaM ([oct+E2]3) (Figure 3A). Mash1 acti-
vated this construct more efficiently (w260-fold) than
E26. Moreover, a mutation in the octamer that interferes
with POU protein binding (octT64G) (Figures 2D and
2F) (Nishimoto et al., 2003) abolished activation of
Developmental Cell
834Figure 2. Activation of the DeltaM Enhancer by Mash1 in P19 Cells Requires an Intact Octamer Sequence
(A) Quantitative reverse transcriptase-PCR experiment showing the time course of expression of Mash1 and Delta1 transcripts in P19 cells after
transfection of a Mash1 expression construct at t = 0 hr.
(B) ChIP analysis of the binding of Mash1 to Delta1 enhancers in P19 cells transfected with a Mash1 construct (black bars) or a control empty
vector (white bars). Data are presented as the mean 6 SD of triplicate quantifications from at least two immunoprecipitations.
(C) Transcriptional assay in P19 cells cotransfected with a Mash1 or Ngn2 plasmid and a reporter construct expressing luciferase under the
control of the DeltaM enhancer (DeltaM) or a shorter version of DeltaM (DeltaM short) described in (D). Data are presented as the mean 6 SD
of quadruplicate assays.
(D) Alignment of the DeltaM enhancer sequences from the mouse Delta1, chick Delta1, and zebrafish DeltaD genes. Conserved residues are in
black, and nonconserved residues are in gray. Black boxes delineate the sequences of two conserved E-boxes (E1 and E2) and a conserved
octamer separated from E2 by one nucleotide. The dashed line outlines the DeltaM short element used in transcription and gel shift assays.
(E and F) Transcriptional assay in P19 cells cotransfected with aMash1 plasmid and reporter constructs expressing the luciferase gene under the
control of wild-type and mutated versions of the DeltaM enhancer (left histograms) or the full-length Delta1 promoter (right histograms). Data are
presented as the mean 6 SD of quadruplicate assays.(octmut+E2)3 by Mash1, thus suggesting that binding of
a POU protein to the octamer sequence increases the
efficiency of the Mash1::E2 interaction.
We then directly addressed the possibility that Mash1
synergizes with a POU protein to activate theDelta1 pro-moter. The experiments described above suggest that
activation of DeltaM in P19 cells involves binding of
a POU protein already present in P19 cells (McEvilly
et al., 2002; Okamoto et al., 1990). To examine the inter-
action of Mash1 with exogenously added POU factors,
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the (oct+E2)3, DeltaM, and Delta1 constructs (AGGTG
CAT or octGG; mutated residues are underlined) that pre-
vents recognition of the mutated octamer by endoge-
nous, wild-type POU proteins. We cotransfected these
mutated reporter constructs with vectors expressing
variant POU proteins harboring two amino acid substitu-
tions in their POUH domain that have been shown to alter
DNA-binding specificity and allow binding to the octGG
sequence (POURR variants [Pomerantz and Sharp,
1994]) (Figure 3B). We produced POURR variants for sev-
eral POU proteins that are expressed in the developing
nervous system, including the class II POU protein
Oct2 and the class III proteins Brn1, Brn2, and Brn4 (Al-
varez-Bolado et al., 1995). Using a gel mobility shift as-
say, we confirmed that wild-type Brn and Oct proteins
were binding efficiently to the intact oct sequence but
that they failed to bind to the mutated octGG, while the
POURR variants were able to bind to both octGG and
oct, albeit with lower affinity than their wild-type coun-
terparts (Figure S1; see the Supplemental Data available
with this article online). As expected, Mash1 failed to ac-
tivate the mutated reporter construct (octGG+E2)3 in P19
cells (Figures 3A and 3C). POURR variants alone did not
activate the mutated construct either, but coexpression
of Mash1 with each of the POURR variants tested
strongly activated (octGG+E2)3, thus demonstrating that
Mash1 efficiently synergizes with POU proteins to ac-
tivate this construct (Figure 3C and data not shown).
Coexpression of Mash1 and POURR variants also acti-
vated the mutated constructs DeltaMGG and Delta1GG,
while each factor alone had only weak or no activity
(Figure 3D and data not shown), establishing that activa-
tion of theDelta1 promoter involves a functional synergy
between Mash1 and a POU protein. The fact that Mash1
synergizes with a mutated POURR even though binding
of POURR to octGG is w1003 weaker than that of a
wild-type POU protein to a wild-type octamer (Pomer-
antz and Sharp, 1994) (Figure S1) suggests that Mash1
synergizes very strongly with endogenous POU proteins
on the Delta1 promoter.
We next examined whether the synergistic activity of
Mash1 and POU proteins was due to cooperative bind-
ing of these factors to the DeltaM sequence. Using a
gel mobility shift assay with a probe corresponding to
the DeltaM short sequence (Figure 2D), we found that
all POU proteins tested, including Oct2, Brn1, Brn2,
and Brn4, were binding with high affinity to the octamer
motif in DeltaM (Figure 3E and data not shown). Using
a probe with a mutated E1-box (E1mut) or a mutated
E2-box (E2mut), we found that Mash1 tethered to E47
(Mash1-E47) was binding only poorly to the E2-box,
while it was binding with high affinity to the E1-box
(Figure 3E, compare lanes 9 and 14), which correlated
well with the strong activation of E16 and the weaker ac-
tivation of E26 by Mash1 in P19 cells (Figure 3A). When
Mash1-E47 and POU proteins were incubated together
with an intact DeltaM short or a E1mut probe, an abun-
dant, slower-migrating band containing both Mash1-
E47 and Brn2 appeared, which disappeared when the
E2-box (E2mut) or the octamer sequence (octmut) was
mutated (Figure 3E, lane 16 and data not shown). These
results demonstrate that Mash1-E47 forms a complex
on the DeltaM short probe with any of the POU proteinstested. Formation of the complex requires intact oct
and E2 sites. Thus, Mash1-E47 binds efficiently to the
E2-box only in the presence of a POU protein bound to
the adjacent octamer, while POU protein binding does
not require that Mash1-E47 binds to the adjacent
E-box. This suggests that the synergistic coactivation
of the Delta1 promoter by Mash1 and a POU protein re-
flects the recruitment by the POU protein of Mash1-E47
to an essential E-box in the DeltaM enhancer.
Brn1 and Brn2 Are Coexpressed with Mash1 In Vivo
The experiments reported thus far have shown that pro-
teins belonging to both POU II and POU III classes have
the capacity to bind the octamer site in DeltaM, recruit
Mash1, and synergistically activate the Delta1 promoter
in P19 cells. We thus asked which POU proteins are
coexpressed with Mash1 in the embryo and could core-
gulate Delta1 expression during neurogenesis. We used
antibodies against Oct2, Brn1, Brn2, Brn4, and Oct6 and
compared their distribution with that of Mash1 in the spi-
nal cord at E10.5 and the ventral telencephalon at E13.5.
Mash1 expression was restricted to progenitor cells in
the ventricular zone (VZ) and subventricular zone (SVZ)
of the ventral telencephalon and in the VZ of the spinal
cord (Figure 4). In the ventral telencephalon and the spi-
nal cord, all Mash1+ cells coexpressed Brn1 and Brn2
(Figures 4A and 4B), while Brn4 was coexpressed with
Mash1 in only a few cells in the spinal cord; Oct6 and
Oct2 were only expressed in Mash1-negative mantle
zone (MZ) cells in both regions (Figures 4A–4C and
data not shown). Triple labeling experiments showed
that many cells coexpressing Mash1 and Brn1 and/or
Brn2 also expressed the Delta1 protein (Figures 4D
and 4E and data not shown). Thus, Brn1 and Brn2 are
the best candidate POU proteins to regulate Delta1
with Mash1 in different CNS regions.
To further examine this possibility, we performed
a ChIP experiment and showed that an antibody against
Brn2 specifically coprecipitated the DeltaM sequence in
chromatin prepared from embryonic telencephalon (Fig-
ure 4G). This result, together with the facts that Brn1 and
Brn2 have similar expression patterns and DNA-binding
properties and that both have been shown to bind to
regulatory elements in the embryonic brain (Miyagi
et al., 2006), suggests that both Brn1 and Brn2 are in-
volved with Mash1 in the regulation of Delta1 in vivo.
Brn Proteins Regulate Notch Signaling In Vivo
We next set out to demonstrate that Brn genes are re-
quired for the expression of Delta1 in the embryonic
CNS by using a dominant-negative strategy to interfere
with the activity of multiple Brn proteins. Brn proteins
share a highly conserved DNA-binding domain, and
they likely act as transcriptional activators since they co-
activate reporter constructs with Mash1 (Figure 3). We
thus produced a chimeric protein (Brn-EnR) containing
the conserved Brn DNA-binding domain fused with the
repressor domain of Drosophila engrailed. When coex-
pressed with Mash1 in P19 cells, it efficiently blocked
the activation of the DeltaM reporter, even when ex-
pressed at a much lower level than Mash1 (Figure 5A).
Transcription of endogenous Delta1 by Mash1 in P19
cells was similarly suppressed by coexpression of
Developmental Cell
836Figure 3. Transcriptional Synergy and Cooperative DNA Binding of Mash1 and POU Proteins on the DeltaM Enhancer
(A) Transcriptional assay in P19 cells cotransfected with a Mash1 plasmid and luciferase reporter constructs containing a multimerized E1-box
(E16), a multimerized E2-box (E26), a multimerized E2-box associated with its adjacent octamer motif ([oct+E2]3), and the same construct with
a mutated octamer sequence ([octmut+E2]3). Data are presented as the mean 6 SD of quadruplicate assays.
(B) Schematic of the two DNA-binding domains of POU proteins (POU-specific domain [POUS] and homeodomain [POUH]) showing an alignment
of the sequences of the POUH domain helix3 of class II and class III POU proteins and the position of the two conserved Val and Asn residues that
are mutated into Arg residues in POU specificity mutant proteins (POURR).
(C and D) Transcriptional assay in P19 cells showing that mutant versions ofBrn1 andBrn2 (Brn1RR and Brn2RR) synergize withMash1 to activate
a multimerized (oct+E2)3 reporter plasmid or the full-lengthDelta1 promoter containing a matching mutated octamer sequence, oct
GG. Data were
treated with one-way ANOVA, followed by Tukey’s post-test (***p < 0.001). Data are presented as the mean 6 SD of quadruplicate assays.
(E) Gel mobility shift assays showing binding of Mash1-E47 and POU proteins to theDeltaM enhancer. In vitro-transcribed and -translated Mash1
tethered to E47 (Mash1-E47) or various Brn proteins (as indicated) were incubated with theDeltaM short probe (Figure 2C) or similar probes con-
taining mutations in the octamer motif (octmut), in the E1-box (E1mut), or in the E2-box (E2mut). The position of Mash1-E47/Brn2, Mash1-E47, and
Brn2 complexes is shown on the left.
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837Figure 4. Coexpression of Mash1 and Brn
Proteins in the Embryonic Telencephalon
and Spinal Cord
(A–C) Immunohistochemical analysis of
Mash1 and (A) Brn1, (B) Brn2, and (C) Brn4
in E13.5 mouse telencephalon (top panels)
and E10.5 mouse spinal cord (bottom
panels). Insets in the upper-left and lower-
left panels indicate the positions of the area
in the telencephalon and spinal cord that
are documented.
(D and E) Triple immunohistochemical label-
ing of (D) E10.5 spinal cord or (E) E13.5 ventral
telencephalon for Mash1, Brn1, or Brn2 and
Delta1.
(F) Binding of Brn2 to the DeltaM enhancer in
E14.5 telencephalon measured by ChIP anal-
ysis with an antibody to Brn2. Data were
treated with one-way ANOVA, followed by
Tukey’s post-test (**p < 0.01, ***p < 0.001).
Data are presented as the mean6 SD of trip-
licate quantifications from two immunopre-
cipitations.Brn-EnR (Figure 5B), thus suggesting that Brn-EnR effi-
ciently inhibits the activity of endogenous POU proteins.
Brn-EnR was then electroporated in the neural tube of
chick embryos. Fourteen hours after electroporation of
a Brn-EnR-IRES-GFP construct in Hamburger-Hamilton
stage-14 embryos, Delta1 transcripts were present in
the nonelectroporated side of the neural tube but were
almost undetectable in the electroporated side, while
electroporation of a control GFP vector did not affect
Delta1 expression (Figures 5C and 5D). Since Delta1
is a Notch ligand, inhibition of Delta1 expression by
Brn-EnR may affect Notch signaling. Indeed, Brn-EnR
electroporation also leads to a severe reduction in ex-
pression of Hes5-1 (Figures 5C and 5D), a direct tran-
scriptional target of the intracellular domain of Notch
(Kageyama and Ohtsuka, 1999). These results thus sug-
gest that Brn activity is required for expression ofDelta1
and for activation of Notch signaling in the neural tube.
Evidence for Brn Protein Functions in Neuronal
Differentiation
The extensive coexpression of Mash1, Brn1, and Brn2 in
neural progenitors (Figure 4) suggested that Mash1 andBrn1/2 could coregulate aspects of neurogenesis other
than Notch signaling. To test this idea, we overex-
pressed Brn2 and Mash1 in the chick neural tube and
compared their effects on different parameters of neuro-
genesis 40 hr after electroporation. While a fraction of
cells electroporated with a control GFP plasmid incor-
porated BrdU after a 1 hr pulse, none of the Brn2- and
Mash1-electroporated cells did, thus showing that
Brn2, like Mash1, promotes cell cycle exit in dividing
progenitors (Figures 6A and 6B). Only a fraction of elec-
troporated cells expressed the neuronal markers HuC/D
and p27 in control experiments, while nearly all Brn2- or
Mash1-electroporated cells expressed these markers,
indicating that Brn2, like Mash1, also induced neuronal
differentiation (Figures 6C and 6D and data not shown).
As expected, Mash1 efficiently promoted neuronal
migration as well, as shown by the accumulation of
Mash1-electroporated cells in the MZ of the neural
tube, while control GFP-electroporated cells were
evenly distributed in both VZ and MZ (Figures 6C and
6E). Brn2 also promoted the migration of electroporated
cells in the MZ, albeit less efficiently thanMash1 (Figures
6C and 6E). Together, these results suggest that Mash1Brn2 protein incubated with the wild-type DeltaM short probe produced a DNA:protein complex (lane 2) that was competed by addition of a 100-
fold molar excess of an unlabeled 12-mer oligonucleotide centered on the octamer motif (lane 3), but not by an unlabeled 12-mer oligonucleotide
centered on the E1-box motif (lane 4). The complex was also supershifted by the addition of an antibody to Brn2 (lane 5), but not by control IgGs
(not shown). Brn2 did not form a complex with theDeltaM short probe containing a T64G mutation in the octamer sequence (octmut probe; lane 7).
Mash1-E47 bound to E1-box (lane 9) was competed efficiently by an excess of E1-box sequence (lane 10), but not octamer sequence (lane 11),
and was supershifted by the addition of an antibody to Mash1 (lane 12) and was unaffected by control IgGs (not shown). Mash1-E47 interacted
only poorly with the E2-box, forming a low-abundance DNA:protein complex (marked by *; lane 14). However, a more abundant complex formed
when the E1mut probe was incubated with both Mash1-E47 and Brn2 (marked by **, lane 16). This complex contained both Mash1-E47 and Brn2
since it was supershifted by an antibody to Mash1 (lane 20) and was disrupted by an antibody to Brn2 (lanes 21 and 22). The complex was
efficiently competed by E1-box sequence (lane 17) and octamer sequence (lane 19). Note that in lane 21, the Brn2:E1mut complex supershifted
by the Brn2 antibody migrates at the same position as the Mash-E47/Brn2:E1mut complex. However, disruption of the Mash-E47/Brn2:E1mut
complex by the Brn2 antibody is demonstrated by the disappearance of the Mash1 antibody-supershifted complex when both Mash1 and
Brn2 antibodies are added to the binding reaction (compare lane 22 with lane 20). Brn1 (lanes 24 and 28), Brn2 (lanes 25 and 29), Brn4 (lanes
26 and 30), and Oct2 (not shown) also formed tripartite complexes with Mash1-E47 and the E1mut probe.
Developmental Cell
838Figure 5. Brn Protein Activity Is Required for Delta1 Transcription and Notch Signaling in the Neural Tube
(A and B) P19 cells were cotransfected with plasmids encoding the DNA-binding domain of Brn4 fused to the Drosophila engrailed repressor
domain (Brn-EnR) and Mash1. The activity of Mash1 on the Delta1 promoter was assayed (A) by using a DeltaM-luciferase construct or (B) by
quantifying the endogenous Delta1 gene by quantitative RT-PCR. Numbers below the histograms designate the relative proportions of the
different constructs transfected. Data are presented as the mean 6 SD of quadruplicate assays.
(C) In situ hybridization analysis of a HH stage-14 chick neural tube, 14 hr after electroporation of a Brn-EnR-IRES-GFP (Brn-EnR-GFP) or GFP
(control) construct.
(D) The reduction in Delta1 and Hes5-1 expression in embryos electroporated with Brn-EnR (white bars) or control plasmid (black bars) was mea-
sured by the fraction of labeled cells in the electroporated over the nonelectroporated side of the neural tube. Data from each Brn-EnR/control
comparison were analyzed with a t test (***p < 0.001). Data are presented as the mean6 SD; six sections from eight embryos were analyzed per
condition.and Brn genes share several activities during neurogen-
esis, raising the possibility that they coregulate target
genes besides Delta1.
Multiple Genes Associated
with a Mash1/Brn-Binding Motif
To address this possibility, we searched the mouse ge-
nome for genes associated with Mash1- and Brn-bind-
ing sites in a configuration similar to that found in the
DeltaM enhancer. By mutagenizing the motif in the
DeltaM enhancer (Figure S2), we defined a 15 bp con-
sensus sequence (ATT[A/T]NCAT[A/T/G]CAG[C/G]TG,
hereafter called a Mash1/Brn motif) that has the prop-
erty to be cooperatively bound and synergistically acti-
vated by Mash1 and Brn proteins. We then identifiedall of the octamers and all the E-boxes conforming to
this consensus sequence that are conserved in whole-
genome alignments of human, mouse, and rat, and we
used the TFBScluster program (Donaldson et al., 2005)
to determine the location of octamer-E-box pairs in the
same configuration as in the Mash1/Brn motif and lo-
cated less than 100 kb away from the nearest gene or
within introns. We found 21 genes that are associated
with a conserved Mash1/Brn motif and are therefore
candidate targets of synergistic regulation by Mash1
and Brn proteins (Figure 7A). All of these genes have
known or predicted activities, and six of them encode
proteins involved in Notch signaling (Delta1 and three
other Notch ligands, the glycosyl transferase Lfng, and
the Delta1-interacting scaffolding protein Magi1
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839Figure 6. Brn2 Promotes Cell Cycle Exit,
Neuronal Differentiation, and Cell Migration
in the Neural Tube
(A) Neural tubes from chick embryos electro-
porated with Mash1-IRES-GFP (Mash1),
Brn2-IRES-GFP (Brn2), or GFP (control) plas-
mids were exposed to BrdU 39 hr after elec-
troporation and were analyzed 1 hr later for
GFP (green) and BrdU (red).
(B) Cell proliferation among electroporated
cells as measured by the fraction of GFP+
cells colabeled by an antibody to BrdU after
a 1 hr BrdU pulse. Data are presented as the
mean 6 SD; ten sections from four embryos
were analyzed per condition.
(C) Neural tubes from chick embryos electro-
porated as in (A), analyzed by histochemistry
for GFP (green) or HuC/D (red).
(D) Neuronal differentiation as measured by
the fraction of GFP+ cells expressing HuC/
D. Data are presented as the mean 6 SD;
ten sections from four embryos were ana-
lyzed per condition.
(E) Neuronal migration as measured by divid-
ing up the electroporated side of the neural
tube in a medial and a lateral bin and deter-
mining the fraction of GFP+ cells located in
the lateral bin. Data are presented as the
mean 6 SD; ten sections from four embryos
were analyzed per condition.[Mizuhara et al., 2005]). Other potential targets are likely
to regulate cellular activities independently of Notch sig-
naling, including cell cycle progression (Cdc25b [Nils-
son and Hoffmann, 2000]), cell differentiation (Insm1
[Mellitzer et al., 2006; Gierl et al., 2006]), and cell migra-
tion (the doublecortin-like kinase Dcamkl1 [Weimer and
Anton, 2006]). We selected 11 of these genes for further
analysis. Seven of them (Delta1, Delta3, Lfng, Stk33,
Insm1, Cdc25b, Fbw7) were coexpressed with Mash1,
Brn1, and Brn2 in the VZ and SVZ of the embryonic ven-
tral telencephalon (Figure 7B), while expression of the
other four (Delta4, Jag2, Plekhg5, and Zic1) was not de-
tected in this tissue (data not shown). Moreover, expres-
sion of these seven genes was markedly reduced in the
ventral telencephalon of Mash1 mutant embryos, sug-
gesting that they are indeed regulated by Mash1 (Fig-
ure 7B). We then examined whether Mash1 and Brn pro-
teins were binding to the Mash1/Brn motifs associated
with these candidate targets by performing ChIP with
chromatin prepared from embryonic telencephalon.
Both antibodies to Mash1 and to Brn2 precipitated
Mash1/Brn motif-containing sequences associated
with Delta1, Delta3, Stk33, Insm1, and Fbw7 (Figure 7C),
while the sequences associated with Lfng and Cdc25b
were not significantly precipitated. These results sug-
gest that Mash1 and Brn genes coregulate multiple tar-
get genes with diverse functions in the embryonic telen-
cephalon, through a cooperative mechanism similar to
that operating on the Delta1 promoter.
Discussion
In contrast with the wealth of information on the cellular
functions of proneural proteins (Bertrand et al., 2002),
virtually nothing is known of the molecular mechanisms
underpinning their activity, including the identity of theirtarget genes and the nature of the coregulators with
which proneural proteins interact to transcribe these
genes. We discuss below the functional synergy be-
tween Mash1 and Brn proteins on the Delta1 promoter
and the identification of a neurogenic program coopera-
tively regulated by Mash1 and Brn factors.
Mechanism Underlying Mash1/Brn
Functional Synergy
We show here that the activation of Delta1 expression
by Mash1, a key aspect of its proneural function (Ber-
trand et al., 2002), involves a functional synergy between
Mash1 and the POU genes Brn1 and Brn2. Many in-
stances of synergistic activity of transcription factors
have been shown to involve cooperative binding to
DNA, as in the recruitment of MyoD by Pbx to the myo-
genin promoter (Berkes et al., 2004). The synergistic ac-
tivation of Delta1 by Mash1 and Brn1/2 likely reflects the
similar recruitment of Mash1 by a Brn protein to the
DeltaM enhancer. Brn1/2 proteins on their own bind
strongly to the consensus octamer sequence present
in this enhancer, while Mash1 alone binds only poorly
to the adjacent E2-box, but Mash1 efficiently forms
a complex with Brn proteins on the octamer-E2 motif.
The configuration of this binding motif plays an essential
role in the recruitment process, since increasing the dis-
tance between the octamer and the E2-box by just one
nucleotide is sufficient to abolish Mash1 recruitment
and enhancer activity (see Figure S2A, lane 27, and
Figure S2B, lane 8). The importance of keeping the two
DNA-binding sites in close proximity strongly suggests
that Mash1-E47 and Brn1/2 physically interact when
bound to DNA.
The interaction of Mash1 and Brn proteins may also
enhance the transcriptional activity of the complex.
This is another well-documented mechanism of
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840Figure 7. Target Genes of Mash1 and Brn1/2 Have Diverse Cellular Functions
(A) List of candidate target genes of Mash1 and Brn proteins, based on their association with an evolutionarily conserved Mash1/Brn-binding
motif. Abbreviated gene names are listed in the left column, and their cellular function characterized in different systems is indicated in brackets.
The sequence of the binding motifs (black for nucleotides diverging from the motif in Delta1, gray for conserved nucleotides), their orientation
with respect to the direction of transcription (F, forward; R, reverse), their distance in kilobases from the transcription start, and their position with
respect to the genes (50 to the first exon, I for intron or 30 to the last exon) are indicated. Confirmed Mash1 and POU targets (see below) are shown
in bold. See Supplemental Data for ENSEMBL gene identifiers.
(B) Expression of Mash1/Brn target genes analyzed by in situ hybridization on frontal sections through the ventral telencephalon of E13.5
wild-type (top panels) and Mash1 null mutant (bottom panels) embryos.
(C) Analysis by ChIP of Mash1 binding (left) or Brn2 binding (right) to genomic sequences spanning the Mash1/Brn motif associated with various
candidate target genes in E14.5 telencephalon. Data were treated with one-way ANOVA, and every sample was compared with each of the three
negative controls by using Tukey’s post-test. The p value shown is the least significant from each three-way comparison (*p < 0.05, **p < 0.01,
***p < 0.001). Data are presented as the mean 6 SD of triplicate quantifications from at least two immunoprecipitations.functional synergy, operating, for example, in the inter-
action between NeuroM, Isl1, and Lhx3 on the HB9 pro-
moter (Lee and Pfaff, 2003). Although the primary mech-
anism underlying the functional synergy of Mash1 and
Brn1/2 on the Delta1 promoter is cooperative bindingto DNA, the role of Brn proteins does not appear to be
restricted to Mash1 recruitment. Indeed, direct binding
of Mash1 to the Mash1/Brn motif in the absence of
Brn protein binding, e.g., when the low-affinity E2-box
sequence in the Mash1/Brn motif is converted to
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841a high-affinity one, is not sufficient to activate a Delta1
reporter construct (see Figure S2A, lane 6, and
Figure S2B, lane 6). This suggests that Brn1/2 also po-
tentiate the transcriptional activity of Mash1, perhaps
by recruiting an essential coactivator or by initiating a
conformational change that exposes the Mash1 activa-
tion domain.
Coregulation of a Program of Neurogenesis
by Mash1 and Brn Proteins
We have found an evolutionarily conserved Mash1/Brn-
binding motif in the vicinity of 21 mouse genes. Six of
them are components of the Notch pathway, which, to-
gether with the finding that a dominant-negative Brn
construct blocks Notch activity in the chick neural
tube, suggests that Mash1/Brn protein complexes play
a major role in regulating Notch signaling in the CNS.
Other genes associated with a Mash1/Brn motif also
have important roles in neural development but act inde-
pendently of Notch signaling. This is notably the case of
Dcamkl1 or doublecortin-like kinase, a microtubule-as-
sociated protein that has recently been implicated in
multiple aspects of development of the cerebral cortex,
including cell cycle progression, neuronal commitment,
neuronal migration, and axon growth (discussed in
Weimer and Anton, 2006).
Some of the other genes associated with a Mash1/Brn
motif have not been previously studied in the developing
nervous system, but studies in other systems suggest
that they may also have varied functions during neuro-
genesis downstream of Mash1 and Brn1/2. The zinc fin-
ger transcription factor Insm1 is regulated by the bHLH
gene Neurogenin3 in the pancreas, where it promotes
neuroendocrine cell differentiation (Mellitzer et al.,
2006; Gierl et al., 2006). Fbw7 is an ubiquitin ligase with
an important role in promoting cell cycle arrest in G1/
G0 through degradation of cyclin E, c-myc, and c-jun
(Nakayama and Nakayama, 2005). Fbw7 has also been
implicated in degradation of Notch1 (Tetzlaff et al., 2004).
Our data thus support the idea that Mash1 acts in syn-
ergy with Brn proteins to activate a genetic program that
controls multiple steps of neurogenesis, including pre-
cursor selection through Notch activation, cell cycle
exit, neuronal differentiation, and migration. Analysis
of Brn1/Brn2 double mutant mice (McEvilly et al., 2002;
Sugitani et al., 2002) has shown that these two genes
regulate neuronal migration and the proliferation of
subventricular zone precursors in the cerebral cortex,
a region where neurogenesis is primarily regulated by
the proneural gene Ngn2. Whether Brn1/Brn2 mutant
mice also display neurogenesis defects in regions
where Mash1 is the main proneural gene remains to be
analyzed.
An important question raised by our results is whether
Mash1 regulates aspects of neurogenesis indepen-
dently of Brn proteins. In support of this notion, we
have identified additional direct targets of Mash1 in the
brain that are not associated with a conserved Mash1/
Brn motif (O.A. et al., unpublished data). Moreover,
a study of Mash1 function in a neuroendocrine prostate
cell line has revealed a number of putative direct targets
in this tissue (Hu et al., 2004) that are not associated with
a conserved Mash1/Brn motif, and some of these genes
are also regulated by Mash1 in the telencephalon inoverexpression experiments (O.A. et al., unpublished
data). These different findings thus support a model
whereby Mash1 interacts with different DNA-binding co-
factors to activate different subprograms of neurogene-
sis, similar to the regulation of different subprograms of
myogenesis by MyoD (Tapscott, 2005).
Biological Implications of Mash1/Brn Factor Synergy
Interactions between transcription factors bound to ad-
jacent sites in a promoter often contribute to the speci-
ficity of the transcription factor-promoter interaction.
Thus, the specificity of NeuroM for the HB9 promoter
lies in the functional synergy between NeuroM and
Isl1/Lhx3, since Mash1 also binds to this promoter but
does not synergize with Isl1/Lhx3 (Lee and Pfaff,
2003). However, the specificity of the regulation of the
DeltaM enhancer by Mash1 is due to the recognition
by Mash1, and not Neurogenins, of the two E-boxes
present in this enhancer (Figures 3A and 3D; D.S.C., un-
published data), suggesting that the distinct DNA-bind-
ing properties of Mash1 and Neurogenins are sufficient
to account for the specificity of the Mash1::DeltaM inter-
action. The specificity of the Drosophila proneural pro-
teins Atonal and Scute for their respective targets has
similarly been attributed mostly to the recognition of dif-
ferent E-box sequences (Powell et al., 2004). Moreover,
when the sequence of the low-affinity E2-box is mutated
to a consensus E-box for Neurogenin binding, Ngn2
functionally synergizes with Brn proteins on this element
(D.S.C., unpublished data), thus demonstrating that the
interaction of Mash1 with Brn proteins does not contrib-
ute to its specificity for the DeltaM element.
Interaction of a transcription factor with distinct DNA-
binding partners on different promoters also allows for
the independent regulation of multiple target genes.
The myogenic program provides examples of such reg-
ulatory modules comprising subsets of genes that are
coordinately regulated by interaction of MyoD with a par-
ticular coregulator in a given cellular context (Tapscott,
2005). Interaction of MyoD with Pbx leads to activation
of a subset of target genes with promoters in a close
chromatin configuration at the beginning of myogene-
sis. Interaction of MyoD with Mef2, a substrate of the
p38 kinase, results in activation of another group of
targets when p38 activity increases later in myogenesis.
Similarly, genes coregulated by Mash1 and Brn1/2 may
be induced in a particular context that does not affect
other components of the neurogenic program. For ex-
ample, the similarity of the Mash1/Brn2 interaction on
the Delta1 promoter with the recruitment of MyoD by
Pbx on the myogenin promoter (Berkes et al., 2004) rai-
ses the possibility that Brn factors mark a subset of tar-
get promoters in a close chromatin configuration for
Mash1 binding and activation. There is indeed evidence
that genes in the neurogenic program are differentially
sensitive to the state of chromatin, with Delta1 requiring
a lower level of histone acetyltransferase activity than
NeuroD for its activation (Koyano-Nakagawa et al.,
1999). Whether recruitment by Brn factors allows
Mash1 to access genes in a repressive chromatin con-
text and to remodel chromatin at these loci remains to
be addressed.
Another biological function ascribed to transcription
factor interactions is the coordination of independently
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842regulated developmental programs. The synergistic
regulation of the motor neuron determinant HB9 by
Isl1, Lhx3, and NeuroM serves as a mechanism by which
to couple neuronal subtype specification with neuronal
differentiation and prevent the subtype specification
program from being prematurely activated in progenitor
cells (Lee and Pfaff, 2003). Transcription factor interac-
tions can synchronize programs, as in the above-
described example, or, on the contrary, can prevent
overlap between programs, as when C/EBP promotes
macrophage fate by synergizing with PU.1 while repres-
sing B cell development by inhibiting Pax5 function (Xie
et al., 2004). In this regard, it is interesting to note that
Brn1 and Brn2 have been shown to regulate expression
of multiple genes in neural stem cells, including Nestin
and Sox2 (Miyagi et al., 2006; Tanaka et al., 2004), in ad-
dition to their role in promoting neurogenesis (this
paper) and cortical neuron migration (McEvilly et al.,
2002; Sugitani et al., 2002). Activation of Nestin and
Sox2 enhancers involves a direct and synergistic inter-
action of Brn1/2 with a SoxB1 protein bound to an adja-
cent sequence (Miyagi et al., 2006; Tanaka et al., 2004).
SoxB1 and proneural proteins have antagonistic activi-
ties during the transition from undifferentiated stem
cells to differentiating neurons, with Sox proteins block-
ing proneural protein function and vice versa (Bylund
et al., 2003). Brn proteins may thus be involved in coor-
dinating two incompatible developmental programs, the
regulation of stem cell-specific gene expression with
Sox proteins and the promotion of neurogenesis with
Mash1, thereby ensuring that neuronal differentiation
is not prematurely initiated in neural stem cells.
Experimental Procedures
Plasmids
DeltaM-Luc has the XhoI/SpeI fragment fromDll1tgHII/lacZ cloned into
p-bglob-Luc. The SpeI/KpnI fragment from Dll1tg4.3Kb/lacZ was in-
serted into PGL3-Basic (Promega) to generate Delta1-Luc. E16,
E26, (oct+E2)3, and (octmut+E2)3 were generated by inserting an-
nealed oligonucleotides (see Supplemental Data) into p-bglob-Luc.
Mutations were generated by using the QuikChange II Site-Directed
Mutagenesis Kit (Stratagene). InE1mut and E2mut, the E-box hexamer
was converted into taggct and tagcct, respectively; other mutations
are as indicated in the figures. rMash1, mNgn2, and POU-EnR
(amino acids 158–361 from rat Brn4 in frame with the EnR domain)
were cloned upstream of an IRES and an NLS-tagged GFP in the
pCAGGS expression vector for transfection of P19 cells and in ovo
electroporation. rBrn1, hBrn2, and mBrn4 cDNAs (gift from Dr. J.
Muhr) or Mash1-E47 were cloned into pcDNA3.1/Zeo(+) for transient
transfection assays and in vitro transcription, and they were cloned
into pCAGGS for in ovo electroporation. Mash1-E47 encodes full-
length rMash1 in frame with full-length mE47 joined by the tether se-
quence SGT(GGGS)4GGGTID. POU specificity mutants were gener-
ated by site-directed mutagenesis (as described above) with oligos
listed in Supplemental Data.
Transgenic Mice
The procedures for generation, genotyping, and lacZ staining of
transgenic animals were as described in Scardigli et al. (2001). Con-
structs Dll1tgHI/lacZ and Dll1tgHII/lacZ, described in Beckers et al.
(2000), were used to generate DeltaM-lacZ and DeltaN-lacZ mouse
lines.
Chromatin Immunoprecipitation Assays
Chromatin immunoprecipitation (IP) assays were performed essen-
tially as described (Skowronska-Krawczyk et al., 2004), with the fol-
lowing modifications: (i) chromatin input per IP reaction was 15 mg
for brain tissue and 10 mg for P19 cells; (ii) salt concentration wasreduced to 20 mM in IP buffer; (iii) after Brn2 IP, beads were washed
seven time with 1 M NaCl and twice with 0.5 M LiCl; (iv) to retrieve im-
munoprecipitates, magnetic beads (Dynabeads M-450 sheep anti-
mouse IgG for Mash1/Ngn2 and Dynabeads ProteinG for Brn2,
Dynal) have been used instead of Sepharose beads. Antibodies
used were mouse anti-Mash1 (Lo et al., 2002), mouse anti-Ngn2
(Lo et al., 2002), and goat anti-Brn2 (c-20; Santa-Cruz). Immunopre-
cipitated DNA sequences were quantified by real-time PCR (primers
are listed in Supplemental Data) by using the iCycler iQ Real-Time
PCR Detection System (BioRad) and a SYBR-Green-based kit for
quantitative PCR (iQ Supermix, BioRad). Quantities of immunopre-
cipitated DNA were calculated by comparison to a standard curve
generated by serial dilutions of input DNA; values obtained with con-
trol antibody were substracted (anti-Flag M2, Sigma). The data were
plotted as means of at least two independent ChIP assays and three
independent amplifications; error bars represent standard devia-
tions. IP efficiency was calculated as the ratio of precipitated se-
quence over total amount of sequence in the input chromatin.
Cell Transfections
Transfections of P19 cells were performed by using Lipofectamine
2000 (Invitrogen). For real-time PCR, RNA was extracted with Trizol
(Invitrogen) and reverse transcribed with Superscript III (Invitrogen).
Primers are listed in Supplemental Data. For ChIP assays, cells were
FACS sorted for GFP expression 24 hr after transfection, and chro-
matin was extracted as described above. For luciferase assays, P19
cell transfections were performed in quadruplicate in 48-well plates
by using Lipofectamine 2000. Each well was seeded 1 day earlier
with 7.5 3 104 cells and transfected with 200 ng appropriated ex-
pression plasmids, 100 ng luciferase reporter plasmid, and 200 ng
CMV-b-gal plasmid as internal control. Cells were lysed 36 hr after
transfection (Passive Lysis Buffer, Promega), and extracts were as-
sayed for luciferase and b-gal activities. Data are represented as
means of quadruplicates, and experiments were repeated three
times.
Immunohistochemistry and In Situ Hybridization
Mouse embryos were fixed in 4% paraformaldehyde for 30 min for
immunohistochemistry or for 3 hr for in situ hybridization. Samples
were cryoprotected in 20% sucrose overnight and embedded in
OCT (Gurr). Ten micron cryostat sections (Leica) were processed
for immunostaining or in situ hybridization (Casarosa et al., 1999).
See Supplemental Data for antibodies and in situ probes used.
Electrophoretic Mobility Shift Assays
Probes (see Supplemental Data) were [g-32P]ATP-labeled (Amer-
sham) with T4 polynucleotide kinase (New England Biolabs). Pro-
teins were produced by coupled in vitro transcription and translation
in rabbit reticulocyte lysates (TNT, Promega). Control reactions with
35S-methionine were performed, and labeled proteins were analyzed
by SDS-polyacrylamide gel electrophoresis (PAGE) to ensure proper
synthesis and equal loading. For gel mobility retardation assays, the
indicated species of proteins were incubated with 1 3 106 cpm
probe in 20 ml binding reactions (30% glycerol, 40 mM HEPES buffer
[pH 7.9], 10 mM MgCl2, 50 ng salmon sperm DNA [Sigma], 0.2 mM
DTT, and 0.02% Triton X-100) and were incubated at room temper-
ature for 20 min. The mixtures were then loaded onto 4% nondena-
turing polyacrilamide gels in 0.53 TBE running buffer (0.045 M Tris
borate, 0.002 M EDTA). For supershift assays, 1 ml of each antibody
was used. Competition oligos were used cold in 1003molar excess
in competition with labeled probes (see Supplemental Data for anti-
bodies and oligos).
In Ovo Electroporations
Chick embryos were staged according to Hamburger and Hamilton
(HH) (Hamburger and Hamilton, 1951). In ovo electroporation, BrdU
labeling, immunochemistry, and in situ hybridization were carried
out as described (Nakada et al., 2004) at HH stage 14 (Figure 5) or
HH stages 10–12 (Figure 6), and embryos were harvested 14 and
40 hr after electroporation, respectively. See Supplemental Data
for antibodies and in situ probes. A minimum of eight (Figure 5) or
four (Figure 6) embryos per condition and ten sections per embryo
were analyzed for each phenotype.
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843In Silico Search for Mash1/Brn Targets
Mapping of Mash1 (CAGSTG) and Brn (ATTWNYAW) conserved
binding sites across mouse, rat, and human genomes was per-
formed by using TFBScluster (Donaldson et al., 2005). To retrieve
the genes associated with the conserved binding sites, a search
for 15 nucleotide clusters with at least one of each binding site (de-
gree of conservation ‘‘non-exact’’) was performed, and clusters
matching the consensus established in Figure S2 were retained.
Supplemental Data
Supplemental Data include Experimental Procedures and two fig-
ures and are available at http://www.developmentalcell.com/cgi/
content/full/11/6/831/DC1/.
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